Coherus BioSciences (CHRS) Insider Trading & Ownership $0.80 +0.02 (+2.35%) (As of 12:15 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Coherus BioSciences (NASDAQ:CHRS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.63%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$450,662.00 Get CHRS Insider Trade Alerts Want to know when executives and insiders are buying or selling Coherus BioSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CHRS Insider Buying and Selling by Quarter Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Coherus BioSciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/22/2023Dennis M LanfearCEOSell223,100$2.02$450,662.00 (Data available from 1/1/2013 forward) CHRS Insider Trading Activity - Frequently Asked Questions Who is on Coherus BioSciences's Insider Roster? The list of insiders at Coherus BioSciences includes Dennis M Lanfear. Learn more on insiders at CHRS. What percentage of Coherus BioSciences stock is owned by insiders? 7.63% of Coherus BioSciences stock is owned by insiders. Learn more on CHRS's insider holdings. Which Coherus BioSciences insiders have been selling company stock? The following insider sold CHRS shares in the last 24 months: Dennis M Lanfear ($450,662.00). How much insider selling is happening at Coherus BioSciences? Insiders have sold a total of 223,100 Coherus BioSciences shares in the last 24 months for a total of $450,662.00 sold. Coherus BioSciences Key ExecutivesMr. Dennis M. Lanfear (Age 69)Chairman, President & CEO Compensation: $1.82MMr. Bryan J. McMichael (Age 45)Former Interim CFO, Principal Financial and Acc. Off., SVP-Acc. & Corporate Controller Compensation: $615.07kMr. Paul Reider (Age 54)Chief Commercial Officer Compensation: $854.06kMr. Richard L. HameisterChief Technical OfficerMs. Jami TaylorVice President of Investor RelationsMr. Andy RittenbergExecutive Vice President of General CounselCheston TurbyfillVice President of CommunicationsMr. Scott SaywellExecutive Vice President of Corporate DevelopmentMs. Rebecca Sunshine (Age 61)Chief Human Resources Officer Mr. Michael ChenSenior Vice President of Commercial Analytics & Trade More Insider Trading Tools from MarketBeat Related Companies BDTX Insider Transactions CMPS Insider Transactions JSPR Insider Transactions STRO Insider Transactions ITOS Insider Transactions DSGN Insider Transactions TNGX Insider Transactions RZLT Insider Transactions ZURA Insider Transactions TSHA Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:CHRS) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coherus BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
